Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma.

Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Abstract Text:

    taek-keun namTaek-Keun Nam,jae-hyuk leeJae-Hyuk Lee,sang-hee choSang-Hee Cho,ik-joo chungIk-Joo Chung,sung-ja ahnSung-Ja Ahn,ju-young songJu-Young Song,mee-sun yoonMee-Sun Yoon,woong-ki chungWoong-Ki Chung,byung-sik nahByung-Sik Nah,taek-keun namTaek-Keun Nam,jae-hyuk leeJae-Hyuk Lee,sang-hee choSang-Hee Cho,ik-joo chungIk-Joo Chung,sung-ja ahnSung-Ja Ahn,ju-young songJu-Young Song,mee-sun yoonMee-Sun Yoon,woong-ki chungWoong-Ki Chung,byung-sik nahByung-Sik Nah,

    The present study evaluated the pretreatment expression patterns of hMLH1, MDM2, p53, and pRb protein to determine whether these could predict the outcome of definitive concurrent chemoradiotherapy (CCRT) in 51 patients with stage I-IVa esophageal squamous cell carcinoma. High immunoreactivies of hMLH1, MDM2, p53, and pRb were detected in 90.2%, 19.6%, 27.5%, and 66.7% of entire patients, respectively. High hMLH1 expression was found to favor earlier stage, less locoregional failure, and longer cause-specific survival, and all were with significance. However, the expressions of MDM2, p53, and pRb were not found to be clinically significant. Thirty-three patients with high hMLH1 and pRb expression tended to survive longer than four patients with low hMLH1 and pRb expression. We suggest that the expression of hMLH1 is a potential marker of tumor response and survival. Determinations of this protein expression might be useful for selecting esophageal squamous cell carcinoma patients for definitive CCRT.

    Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Publishing Authors By Initials

    tk namTK Nam,jh leeJH Lee,sh choSH Cho,ij chungIJ Chung,sj ahnSJ Ahn,jy songJY Song,ms yoonMS Yoon,wk chungWK Chung,bs nahBS Nah,tk namTK Nam,jh leeJH Lee,sh choSH Cho,ij chungIJ Chung,sj ahnSJ Ahn,jy songJY Song,ms yoonMS Yoon,wk chungWK Chung,bs nahBS Nah,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Cancer letters

    VOLUME: 260

    Page Numbers: 109-17

    Journal Abbreviation: Cancer Lett.

    ISSN: 0304-3835

    DAY: 28

    MONTH: 11

    YEAR: 2007

    Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7600053

    Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma.

    AFFILIATION: Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Republic of Korea.

    Country: Ireland

    Ireland Research PublicationIreland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Lett

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News